Rationale e have previously shown increased expression of the Fri led-8 receptor of the T signalling pathway in COPD. ere, we investigated if the Fri led-8 receptor has a functional role in airway inflammation associated with chronic bronchitis.
ntroduction
Chronic obstructive pulmonary disease (COPD) is a complex lung disease, characterized by airflow limitation that is not fully reversible. Airflow limitation is usually progressive and associated with chronic inflammation, remodelling of the small airways, and emphysema development in some patients [1, 2] .
The heterogeneity of COPD is represented by different phenotypes within the patient population, chronic bronchitis being one of them. Chronic bronchitis is defined by chronic cough and idiopathic sputum production for at least three months per year for two consecutive years [1] . Inflammatory signals can cause mucus cell metaplasia, resulting in more mucus by both an increased production of mucus by goblet cells and decreased elimination from the airways [3] . This is defined in patients as chronic mucus hypersecretion (CMH). CMH is associated with bronchial inflammation, accelerated lung function decline [4] , increased mortality [5] , and is a risk factor for COPD [6] .
COPD treatment is not curative nor directed at different COPD phenotypes, including chronic bronchitis. At present, the pathophysiology and underlying mechanisms of chronic bronchitis are poorly understood. This hampers the development of targeted drugs. Therefore, a better understanding of the mechanisms behind chronic bronchitis is needed.
The wingless/integrase-1 (WNT) signalling pathway plays an important role in lung development [7] . Recent studies indicate involvement of the WNT signalling pathway in remodelling [8, 9] and inflammation [10, 11] in the lung. WNT ligands bind to transmembrane Frizzled (FZD) receptors, thereby controlling cell differentiation, growth and polarity [12] . Our previous results showed that FZD8 expression is higher in pulmonary fibroblasts of moderate (GOLD grade 2) and severe (GOLD grade 4) COPD patients after stimulation with transforming growth factor (TGF)-β compared to control fibroblasts [8] . However, the functional role for FZD8 in COPD is as yet unknown. WNT-3A [10] , WNT-4 [13] and WNT-5A [14] have recently been shown to function as pro-inflammatory stimuli in the lung. Importantly, we previously showed that WNT-5A is a ligand for FZD8 in airway smooth muscle cells [9] , reinforcing the possibility that the increased FZD8 expression in COPD fibroblasts may play a role in pro-inflammatory signalling in the lung.
Here, we aimed to investigate the link between FZD8 and airway inflammation in COPD. We studied the role of FZD8 in acute cigarette smoke-induced airway inflammation in vivo using a mouse model and in vitro in human lung fibroblasts obtained from COPD patients with and without CMH. Furthermore, we investigated the association between single nucleotide polymorphism (SNP)s in the FZD8 region and CMH, and their roles as cis-expression quantitative trait loci (eQTL), regulating FZD8 expression in lung tissue.
Methods

Ethics statement
For the genetics study on CMH approval by the local medical ethics committee and written informed consent from all patients was obtained. At Laval, lung specimens were collected from patients undergoing lung cancer surgery and stored at the "Institut universitaire de cardiologie et de pneumologie de Québec" (IUCPQ) site of the Respiratory Health Network Tissue Bank of the "Fonds de recherche du Québec -Santé" (www.tissuebank.ca).
Wri en informed consent was obtained from all subjects and the study was approved by the C ethics commi ee. At Groningen lung specimens were provided by the local tissue bank of the Department of athology and the study protocol was consistent with the esearch Code of the niversity Medical Center Groningen and Dutch national ethical and professional guidelines ( Code of conduct; Dutch federation of biomedical scientific societies ; h p://www.federa.org). At ancouver the lung specimens were provided by the James ogg esearch Center Biobank at St. aul s ospital and subjects provided wri en informed consent. The study was approved by the ethics commi ees at the BC-rovidence ealth Care esearch nstitute Ethics Board. All animal experiments were performed according to the national guidelines and approved by the niversity of Groningen Animal Ethical Commi ee (commi ee approval number 5 12B).
Animal studies
eterozygous inbred specified-pathogen-free breeding colonies F D8 -/-and WT mice were subjected for four successive days to fresh air or cigare e smoke from entucky 3 4F research cigare es (Tobacco esearch nstitute niversity of entucky Lexington SA) by whole body exposure as described previously 22 . n brief cigare e smoke was directly circulated into a 6-liter erspex box. A er removing the filter each cigare e was smoked in five minutes at a rate of 5L/hour in a ratio of 60L/hour air using a peristaltic pump (45 rpm Watson Marlow 323 E/D o erdam the Netherlands). n the first day mice were exposed to one cigare e in the morning and three cigare es in the a ernoon. n the second to fourth day mice were exposed to five cigare es in the morning and five cigare es in the a ernoon. Control animals were exposed at the same time intervals to fresh air. Eight mice were included in each group. Sixteen hours a er the last cigare e smoke exposure mice were euthanized by subcutaneous injection with a mixture of medetomidine (0.5 mg/kg Dormitor rion harma Mechelen Belgium) and ketamine (40.0 mg/kg Alfasan Woerden the Netherlands) followed by exsanguination. The lungs were lavaged five times with 1 mL BS. The bronchial alveolar lavage fluid (BALF) fractions were pooled. From these cytospins were prepared to determine total and inflammatory cell numbers. Cytospins were stained with May-Gr nwald and Giemsa (Sigma St. Louis M SA). Di erential cell count was performed by counting 400 cells in duplicate in a blinded manner. receding immunohistochemistry the upper right lung lobe was taken up in formalin and para n-embedded. receding m NA isolation the post caval lobe was snap frozen mechanically crushed under li uid nitrogen and taken up in lysis bu er.
enetic association
Genetic association studies for FZD8 and CM were performed in the NELS N cohort; a large cohort of smoking individuals with and without C D which was originally set-up to detect lung cancer 15 . A er uality control 717 heavy smokers with CM (cases) and 1 7 5 heavy smokers without CM (controls) all with 20 pack-years were included for the analysis as previously published 16 . Six SN s were tested using multivariate logistic regression analysis under an additive model with adjustment for ex-or current smoking and the two population sites (Groningen and trecht).
ression uantitati e trait loci e T analysis in lun tissue
The lung eQTL analysis was performed in a large dataset of lung tissue samples where both genotype and genome-wide gene expression data is available through a collaboration of three universities (Laval University, Quebec City, Canada; University of British Columbia, Vancouver, Canada; University of Groningen, Groningen, the Netherlands), and Rosetta/Merck Sharpe and Dohme as has been described previously, including patient characteristics [17] . After quality control, 1,095 patients out of 1,111 were included in the analysis. A cis-eQTL analysis was performed to determine the association between SNP rs663700 and the regulation of gene expression of genes within 100 kb [17] . In short, the association between genotype and expression of cis-eQTL genes was analyzed using linear regression on imputed data, first in the three cohorts separately, followed by a meta-analysis [18, 19] .
Fibroblast cell culture
Human airway and parenchymal lung fibroblasts from ex-smoking GOLD grade 4 COPD patients with and without CMH were isolated from transplanted lungs as has been described previously [20] . Presence of CMH was defined by patient records. Patient characteristics are shown in table 1 and showed no differences in age, gender, smoking status, lung function or medication use. At the same time, we determined that none of the patients used for the study in fibroblasts was diagnosed with bronchiectasis, excluding the possible influence on the data. MRC-5 human lung fibroblasts [21] were obtained from Sigma (St. Louis, MO, USA). Primary human airway and parenchymal lung fibroblasts and primary MRC-5 human lung fibroblasts were cultured in Ham's F12 medium supplemented with 10% (v/v) fetal bovine serum (FBS), 2 mM L-glutamine, 50 μg/ml streptomycin, 50 U/ml penicillin and 1.5 μg/ml amphotericin B. Prior to the experiment, cells were grown to confluence in 6-well or 24-well cluster plates and placed in Ham's F12 medium with 0.5% (v/v) FBS for 24 hours. Subsequently, cells were stimulated with either 2 ng/ml recombinant human transforming growth factor (TGF)-β1, 1 ng/ml recombinant human interleukin (IL)-1β, 10 ng/ml recombinant human tumor necrosis factor (TNF)-α, 10 ng/ml recombinant human epidermal growth factor (EGF) or 5% cigarette smoke extract (CSE) for several time points. To prepare CSE, two cigarettes were smoked sequentially using a peristaltic pump (323 E/D; Watson Marlow, Rotterdam, the Netherlands) at 45 rpm through 25 ml of Ham's F12 medium supplemented with 0.5% (v/v) FBS, referred to as 100% CSE. 100% CSE was diluted to a working concentration of 5% CSE. CSE was freshly prepared before each experiment.
Air liquid interface (ALI) cell culture
Human airway epithelial cells were isolated after incubating tracheal tissue from donor lungs for 2 hours at 37°C in Protease IX (Sigma, St. Louis, MO, USA) and plated on coated culture dishes. Coating consisted of 10 μg/ml bovine serum albumin, 10 μg/ml fibronectin (both from Sigma, St. Louis, MO, USA) and 30 μg/ml collagen (PureCol®, Advanced Biomatrix, San Diego, CA, USA) in phosphate buffered saline (PBS). Human airway epithelial cells were grown to approximately 70% confluence in keratinocyte serum-free medium (KSFM) supplemented with 25 μg/ml streptomycin, 25 U/ml penicillin, 1 μM isoproterenol, 0.2 ng/ml EGF, 25 μ/ml bovine pituitary extract. For the first week after isolation, KSFM medium was additionally supplemented with 1.5 μg/ml amphotericin B and 5 μg/ml ciproxin. Cells were plated on a 0.4 μm polyester membrane 12 mm inserts (Transwell® Permeable Supports, Corning, NY, USA) coated well in 1:1 Bronchial Epithelial Cell Growth Medium (Lonza, Walkersville, MD, USA)/Dulbecco's Modified Eagle's Medium (Gibco, Grand Island, NY, USA) (BEGM/DMEM) medium supplemented with 25 μg/ml streptomycin, 25 U/ml penicillin, 5.5 mg/ml sodium pyruvate (all from Gibco, Grand Island, NY, USA) 0.4% (w/v) bovine pituitary extract, 0.5 ng/ml EGF, 5 µg/ml insulin, 10 µg/ ml transferrin, 1 µM hydrocortisone, 6.5 ng/ml T3, 0.5 µg/ml epinephrine (all from Lonza, Walkersville, MD, USA), 15 ng/ml retinoic acid and 1.5 µg/ml bovine serum albumin (Sigma, St. Louis, MO, USA). When confluence was reached, cells were air-exposed and allowed to differentiate into mucociliary epithelium for 14 days. Subsequently, cells were serum deprived for 16 hours in BEGM + ITS (5 µg/ml insulin, 5 µg/ml transferrin, and 5 ng/ml selenium) and stimulated basolaterally for 24 hours with 10 ng/ml recombinant human IL-6 or 10 ng/ml recombinant human chemokine ligand (CXCL)8 to measure MUC5AC gene expression and to perform immunohistochemistry for goblet cells.
Immunohistochemistry
Inserts of ALI cell culture were taken up in formalin and paraffin-embedded according to the protocol 'Preparation of Costar® Transwell® Inserts for Histology'. Transverse crosssections of 5 μm thick were used for morphometric analyses. Paraffin-embedded sections were stained for goblet cells with Periodic Schiff's (PAS, Sigma-Aldrich, Zwijndrecht, the Netherlands). PAS-positive cells were counted and expressed per mm basement membrane.
After sacrificing the mice, the upper right lung lobe was taken up in formalin and paraffin-embedded. Transverse cross-sections of 5 μm thick were used for morphometric analyses. Paraffin-embedded sections were stained for α-smooth muscle(sm)-actin using rabbit anti-α-sm-actin antibody (Abcam, Cambridge, UK) and visualized using a goat anti-rabbit horseradish peroxidase (HRP)-conjugated secondary antibody (Santa Cruz Biotechnology, CA, USA) and diaminobenzidine (Sigma-Aldrich, Zwijndrecht, the Netherlands). The presence of α-sm-actin around the airway was quantified using ImageJ [chapter 2 ref 25] . The surface of positively stained tissue was expressed as mm2 per mm2 basement membrane. MUC5AC positive cells were stained in paraffin-embedded sections using a MUC5AC antibody staining (Neomarkers, Fremont, CA, USA).
all interferin ( i) A tran fec n
Human fibroblasts were grown to 90% confluence and transfected with specific siRNA against the FZD8 transcript to knockdown FZD8. Cells were transfected in serum-free Ham's F12 medium without supplements using 100 pmol FZD8-targeted siRNA or nontargeting control siRNA and Lipofectamine® 2000 Transfection Reagent. After 6 hours, the medium was changed to medium supplemented with 10% (v/v) FBS for 18 hours and subsequently to medium supplemented with 0.5% (v/v) FBS for 24 hours. Cells were stimulated with either recombinant human IL-1β or EGF in increasing concentrations (0.03-3 ng/ml IL-1β and 0.1-10 ng/ml EGF) for 24 hours. Knockdown was considered successful when FZD8 gene expression was reduced by 60%.
t ine relea e fr r la t 24 hours after stimulation, culture medium was collected for the determination of cytokines using enzyme-linked immunosorbent assay (ELISA) and Milliplex®. We used Milliplex® (MILLIPLEX MAP Human Cytokine/Chemokine -Premixed 26 Plex, Millipore, Billerica, MA, USA) to screen for primary MRC-5 human lung fibroblast cytokine release. We specifically measured concentrations of secreted IL-6 and CXCL8 in primary MRC-5 human lung fibroblasts by ELISA according to the manufacturer's instructions (#M1916 (IL-6), #M1918 (CXCL8); Sanquin, Amsterdam, the Netherlands).
A i la n and real e anal i Total mRNA from primary MRC-5 human lung fibroblasts and from mice lung tissue was extracted using the NucleoSpin® RNA II kit (Macherey-Nagel GmbH & Co. KG, Düren, Germany). Total mRNA from primary human airway and parenchymal lung fibroblasts was extracted using the miRNeasy Micro Kit (Qiagen, Venlo, the Netherlands). Total mRNA from differentiated primary human airway epithelial cells was extracted using Tri Reagent® Solution (Applied Biosystems, Life Technologies Europe BV, Bleiswijk, the Netherlands). The eluted mRNA was quantified using spectrophotometry (Nanodrop, Thermo Scientific™, Wilmington, DE, USA). Equal amounts of mRNA (1 µg) were then reverse transcribed using the Reverse Transcription System (Promega Benelux b.v., Leiden, the Netherlands) and the cDNA was stored at -20°C till further use. mRNA expression was determined using real-time PCR, which was performed with the Illumina Eco Personal QPCR System (Westburg, Leusden, the Netherlands). Primer sets are listed in table 2-3. To test di erences between di erent patient groups, one-way ANOVA on ranks was used. For comparison between multiple conditions within the primary MRC-5 human lung broblast experiments and within the di erent groups of mice, two-way ANOVA was used. Tests used for the analyses of the genetic studies are described in the appropriate sections. Where appropriate, ANOVA was followed by a post hoc analysis using the Student-Newman-Keuls multiple comparisons test. P 0.05 was considered signi cant.
Results
FZD8 regulates cigarette smoke-induced airway inflammation in mice
In ammation in COPD follows a characteristic pattern of increased numbers of macrophages, lymphocytes and neutrophils 2 . To investigate a possible role for FZD8 in in ammation, we used FZD8 --mice and studied acute cigarette smoke-induced airway in ammation, as described previously 22 . FZD8
--mice were born according to normal Mendelian ratio and survived after birth with no di erences compared to WT mice. Baseline lung structure was not di erent for the FZD8 --mice and WT mice in terms of gross morphological structure and expression of α-sm-actin around the airways and vessels ( gures 1A-C). Baseline presence of in ammatory cells and pro-in ammatory cytokines was slightly higher in FZD8 --mice compared to WT mice ( gures 2A-G) and this was signi cant for neutrophil number (p 0.004) and CXCL5 (p 0.005) gene expression when using a Student's t-test on the air exposed animals only.
Four days of cigarette smoke exposure induced an increase in the number of lymphocytes and neutrophils in the bronchial alveolar lavage uid (BALF) of WT mice ( gures 2A-B) . No e ect of cigarette smoke was found on total cells and macrophages ( gures 2C-D). Notably, cigarette smoke did not increase the number of lymphocytes and neutrophils in FZD8
--mice and neutrophil number in cigarette smoke exposed FZD8 --mice was signi cantly lower compared to cigarette smoke exposed WT mice ( gure 2B). Keratinocyte-derived cytokine (KC), CXCL2 and CXCL5 are chemotactic for neutrophils and the gene expression of all three cytokines was increased upon cigarette smoke exposure in WT mice ( gure 2E-G). KC and CXCL2 tended to be reduced in FZD8 --mice, whereas for CXCL5, the cigarette smoke-induced increase was completely absent in FZD8 --mice. Gene expression of FZD8 and its putative ligands WNT-5A and WNT-5B was also measured in whole lung homogenates and was not di erent between groups, although small, nonsigni cant increases in cigarette smoke exposed WT mice were apparent for all three genes ( gures 1D-F). MUC5AC gene expression signi cantly increased after cigarette smoke exposure in WT mice but not in FZD8 --mice ( gure 1G). However, consistent with previous studies 22, 23 we did not nd any cells positive for MUC5AC protein expression in lung tissue sections before and after cigarette smoke exposure in WT and FZD8 --mice. Together, these results suggest that FZD8 is involved in acute cigarette smoke-induced airway in ammation in mice in vivo. (G) KC gene expression in whole lung homogenates. Data represent mean ± s.e.m. of 8 mice per group. * p < 0.05 ** p < 0.01 *** p < 0.001 compared to air exposed WT mice # p < 0.05 compared to smoke exposed WT mice $ p < 0.05 compared to air exposed FZD8 -/-mice (two-way ANOVA with Student-Newman-Keuls multiple comparisons test). ^^ p < 0.01 compared to air exposed FZD8 -/-mice (two-tailed Student's t-test).
A genetic association between FZD8 and CMH
In view of this pro-in ammatory role, we next studied the role of FZD8 in chronic bronchitis and found a genetic association between SNP rs663 00 in the FZD8 region and CMH (p 0.00 OR 0.805 0.684 -0. 4 5) in a large cohort of smoking individuals with and without COPD, implying that FZD8 may play a role in the development of CMH ( gure 3A). Notably, we found that SNP rs663 00 was associated with CMH already in the healthy smokers of the cohort (n 1348 p 0.002), indicating that the SNP links to CMH speci cally and is independent of the presence of COPD. The protective C allele is associated with lower risk of having CMH and the susceptibility allele T with higher risk of having CMH. The ve other SNPs tested in the FZD8 region were less or not associated with CMH (table 4) . Next, we performed an eQTL analysis in a large dataset of lung tissue samples of non-, current-and ex-smokers with and without COPD 1 to determine the association between SNP rs663 00 and the lung mRNA expression levels of genes within 100 kb, as has been described previously 1 . The eQTL analysis showed that SNP rs663 00 has a cis-eQTL e ect on FZD8 (p 4.58 10 ) gene expression in lung tissue (n 1,0 5). The strongest eQTL e ect was on FZD8 where the protective C allele is associated with lower expression and the susceptibility allele T with higher expression of FZD8 (results from the meta-analysis across the three cohorts p 4. 4 10 -10 Spearman 0.1 gures 3B-E). The allele frequency within the study population was 65.8 for the homozygous CC, 30.3 for the heterozygous CT and 3. for the homozygous TT.
FZD8 expression in lung fibroblasts is associated with CMH
We previously established that FZD8 is expressed in broblasts and that its expression is increased in COPD 8 . To link these previous ndings with the current observation that FZD8 regulates in ammation and is involved in chronic bronchitis, we studied the pro-in ammatory role of FZD8 in human airway and parenchymal lung broblasts from ex-smoking GOLD grade 4 COPD patients with and without CMH. We found that interleukin (IL)-1β and epidermal growth factor (EGF) induced a strong increase in FZD8 gene expression in lung broblasts. Interestingly, this normalized increase in FZD8 gene expression was stronger in primary airway and parenchymal lung broblasts of GOLD grade 4 COPD patients with CMH than in those without CMH ( gures 4A,C). The mean basal FZD8 gene expression did not di er with respect to CMH status. No di erences in gene expression with respect to CHM status were observed for the e ects of IL-1β or EGF on WNT-5A, WNT-5B, WNT-16, FZD2 and FZD6 gene expression in parenchymal lung fibroblasts (figures 5A-B), indicating a specific effect on FZD8. Although TGF-did augment FZD8 gene expression, there was no significant difference between the two patient groups regarding CMH status, whereas tumor necrosis factor (TNF)-α and cigare e smoke extract did not augment FZD8 gene expression ( figure 5C ). This indicates a specific effect for IL-1 and EGF. Interestingly, receptor expression of EGFR was higher in airway fibroblasts and pulmonary fibroblasts of GOLD grade 4 COPD patients with CMH than without CMH, as well as IL1R1 expression in airway fibroblasts of GOLD grade 4 COPD patients with CMH than without CMH (figures 4B,D), suggesting a link between receptor expression and functional FZD8 induction by IL-1 and EGF. ene e re i n in lun r la t i re ulated r We further analyzed the genetic basis of FZD8 gene expression in airway and parenchymal lung fibroblasts of GOLD grade 4 COPD patients with and without CMH. The fold induction of FZD8 gene expression after stimulation with IL-1β and EGF was found to be dependent on the genotype of the patients with respect to SNP rs663700. In line with the results of our lung eQTL analysis, airway fibroblasts of GOLD grade 4 COPD patients with the CT variant showed a higher induction of FZD8 gene expression than did patients with the CC variant after IL-1β but not after EGF stimulation ( figures 6A-B) . In parenchymal lung fibroblasts, this effect was less pronounced ( figure 7A-B) . The low allele frequency (3.9%) of the TT variant precluded us from obtaining sufficient numbers of donors to analyze the impact of the TT variant on gene expression in these studies. Our results suggest that variants in FZD8 gene expression in lung fibroblasts play a role in COPD patients who have CMH. --mice, our next aim was to investigate in what way the changed expression in FZD8 gene expression in lung broblasts may a ect proin ammatory responses. We investigated which cytokines are produced by primary MRC-5 human lung broblasts in response to IL-1β and EGF. Stimulation with IL-1β induced granulocyte colony-stimulating factor (G-CSF), granulocyte macrophage colony-stimulating factor (GM-CSF), IL-6, chemokine ligand CXCL8, interferon gamma-induced protein (IP)-10 and monocyte chemotactic protein (MCP)-1 secretion ( gure 8A). Stimulation with EGF induced GM-CSF, IL-6 and CXCL8 secretion ( gure 8B). We hypothesized that FZD8 may regulate the IL-1β-and EGF-induced release of IL-6 and CXCL8 from broblasts, as these cytokines are increased in COPD and contribute largely to the in ammation seen in COPD 24 . Moreover, in accordance with a previous study 25 we observed that IL-6 and CXCL8 induce MUC5AC gene expression and CXCL8 induces PAS positive mucin protein expression indicative of goblet cell di erentiation in di erentiated primary human airway epithelial cells from healthy donors ( gures 8C-D), further linking these cytokines to CMH. We were, however, not able to detect MUC5AC protein release. We found that IL-1β dose-dependently increased both IL-6 and CXCL8 secretion from primary MRC-5 human lung broblasts ( gures A-B), whereas EGF dose-dependently increased CXCL8 secretion ( gure C), but not IL-6 secretion ( gure 10A). FZD8 knockdown by speci c siRNA (knockdown e ciency 65 on average see gures 10B-C) signi cantly reduced IL-1β-induced IL-6 secretion (p 0.03 for the interaction of IL-1β stimulation and siRNA knockdown (two-way ANOVA) and CXCL8 secretion (p 0.008 for the interaction of IL-1β stimulation and siRNA knockdown (two-way ANOVA)) ( gures A-B). EGF-induced CXCL8 secretion was also reduced by FZD8 knockdown (p 0.001 for the interaction of EGF stimulation and siRNA knockdown (two-way ANOVA) ( gure C). These data show that FZD8 is involved in the IL-1β-induced secretion of IL-6 and CXCL8 as well as in the EGF-induced secretion of CXCL8. Furthermore, these data stress the importance of the broblast in the in ammatory response as seen in chronic bronchitis in COPD.
i ure IL and L are relea ed ri ar u an lun r la t and induce A ene e re i n in ALI cultured ri ar u an air a e it elial cell Primary MRC-5 human lung fibroblasts were stimulated for 24 hours with IL-1β (1 ng/ml) or EGF (10 ng/ml). A Milliplex® was performed to screen for 26 cytokines to investigate which cytokines were produced. 
Discussion
This study shows for the first time that FZD8 plays a critical role in inflammatory processes involved in chronic bronchitis, including CMH, and reveals an unexpected role for the fibroblast in this process. We found that acute cigare e smoke-induced airway inflammation in an in vivo mouse model is partly FZD8 dependent. In FZD8 -/-mice, cigare e smoke did not induce neutrophilic inflammation, which was accompanied by the reduced expression of CXCL5 and to a lesser extent of CXCL2 and KC compared to cigare e smoke exposed WT mice. Furthermore, we show that there is an association between pro-inflammatory cytokine-induced FZD8 gene expression in airway and parenchymal lung fibroblasts of GOLD grade 4 COPD patients and the presence of CMH. This is explained in part by increased EGFR and IL1R1 receptor expression in fibroblasts of GOLD grade 4 COPD patients with CMH compared to patients without CMH and in part by a polymorphism in the FZD8 region. SNP rs663700 in the FZD8 region is associated with CMH in a cohort of smokers and additionally is a cis-e TL in lung tissue, regulating FZD8 expression. Moreover, SNP rs663700 is associated with increased FZD8 gene expression in fibroblasts of GOLD grade 4 COPD patients with CMH. Upon stimulation with IL-1 and EGF, primary MRC-5 human lung fibroblasts secrete IL-6 and CXCL8, a process which is regulated by FZD8, and we show that both of these cytokines are able to initiate MUC5AC gene expression and CXCL8 induces goblet cells in differentiated primary human airway epithelial cells.
COPD is a heterogeneous disease characterized by different patient subpopulations [26] . We investigated the potential role for FZD8 in chronic bronchitis, and found a clear association between the cytokine-induced expression of FZD8 gene expression and CMH, a clinical expression which is a consequence of the pathologic process in chronic bronchitis. Of importance is to emphasize that the genetic association was independent of the presence of COPD, indicating that FZD8 likely plays a role in CMH in healthy smokers as well. CMH is associated with bronchial inflammation, accelerated lung function decline, COPD morbidity and increased mortality [4] [5] [6] . The association of the genetic variance in FZD8 with CMH is the first evidence to support a genetic link between the WNT signalling pathway and a phenotype of COPD. Interestingly, we also found a specific role for FZD8 in the chronic bronchitis phenotype, reinforcing the contention that phenotypes of COPD may be characterized by specific pathophysiological mechanisms.
While the communication of both damaged and intact epithelium to the fibroblasts is widely recognized in the airways [27], we now find indications that fibroblasts play an additional crucial role in inflammation and epithelial mucus production. Upon damage, the epithelium secretes inflammatory cytokines such as EGF, IL-1 and IL-1α. IL-1α has been shown to induce IL-6 and CXCL8 in fibroblasts [28] . Importantly, IL-6 and CXCL8 secretion from primary MRC-5 human lung fibroblasts are increased upon co-culturing these cells with human bronchial epithelial (16-HBE) cells. This process is mediated via IL-1α [2 ] . IL-1α and IL-1 are known to function via the same receptor, IL1R1. IL-1 and EGF stimulated fibroblasts to produce IL-6 and CXCL8 via FZD8 in our study. We propose that in this way FZD8 contributes to the inflammation present in chronic bronchitis. Our data support this hypothesis, as neutrophil and lymphocyte recruitment in the BALF are reduced in FZD8 -/-mice as well as mRNA expression of the neutrophil a ractants CXCL5 and KC in whole lung homogenates, whereas IL-6 and CXCL8 induced mucus production in differentiated primary human airway epithelial cells. Both cytokines are secreted by human lung broblasts upon stimulation with IL-1β and EGF, and we demonstrate that this process is regulated by FZD8. In addition, we show that expression of IL1R1 and the EGFR is increased in broblasts of GOLD grade 4 COPD patients with CMH compared to patients without CMH. This shows that IL-1β and EGF lead to increased FZD8 expression in CMH in part via increased expression of their receptors, and in part based on FZD8 genotype.
For many WNT ligands, it is either not known or highly context dependent via which FZD receptor they exert their e ect. FZD8 is a known receptor for WNT-5A and WNT-5B 30 in airway smooth muscle cells and pulmonary broblasts. However, based on the crystal structure of the cysteine rich domain of FZD8, it must be assumed that most if not all WNT ligands are potential agonists 31 , whereas R-spondins have also been described as FZD8 agonists 32 . Conversely, connective tissue growth factor 33 and insulin-like growth factor-binding protein-4 34 may antagonize FZD8 by direct binding. WNT-5A and WNT-5B are highly expressed in broblasts 8 , and a role of FZD8 in their responses has been described , 30 Furthermore, the regulation by WNT-5A of CXCL8 release from human neutrophils has been described 14 Therefore, WNT-5A and WNT-5B are potential ligands for FZD8 in chronic bronchitis, which is supported by our ndings that WNT-5A and WNT-5B induce IL-6 and CXCL-8 release from human lung broblasts 35 . Clearly, a better appreciation of the ligands involved in FZD8 signalling, their cellular sources and their role in chronic bronchitis require further studies.
COPD is currently treated symptomatically and not phenotype speci c. The awareness that COPD patients need treatment according to their phenotype stimulated the investigation of new drug targets 24 . We found IL-6 and CXCL8 to be important in inducing mucus production. There are no biologicals used in COPD that target IL-6. Blocking CXCL8 by using a blocking antibody only or by blocking the CXCR2 receptor has been reported not to have a clinical impact 36 . Our data show that targeting FZD8 on broblasts could prevent both the secretion of IL-6 and CXCL-8, leading to a reduction in in ammatory processes and mucus secretion. Therefore, FZD8 may provide a rational drug target for chronic bronchitis and the development of FZD8 receptor antagonists may be warranted.
In conclusion, our results indicate that FZD8 plays an important pro-in ammatory role in chronic bronchitis. Interestingly, the broblast appears to play a ma or role herein. We provide genetic and functional data in vitro and in vivo supporting the role of FZD8 in pro-in ammatory cytokine production, in ammatory cell recruitment and mucus hypersecretion. These ndings show a potential important role for WNT signalling via FZD8 in broblasts in chronic bronchitis. Therefore, targeting FZD8 is a strategy worth pursuing for the treatment of chronic bronchitis.
